Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
24.92
-0.62 (-2.43%)
Jun 26, 2026, 3:26 PM EDT - Market open
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $100.82 million as of June 26, 2026. Its market cap has increased by 109.60% in one year.
Market Cap
100.82M
Enterprise Value
89.33M
1-Year Change
109.60%
Ranking
Category
Stock Price
$24.92
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $100.82M, a decrease of -47.90%. That is a compound annual growth rate of -7.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 100.82M | 320.08% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 109.36M |
| Aldeyra Therapeutics | 108.58M |
| Alps Group | 108.16M |
| Verrica Pharmaceuticals | 106.68M |
| Kalaris Therapeutics | 102.31M |
| Cibus | 102.28M |
| Pelthos Therapeutics | 101.52M |
| Cognition Therapeutics | 101.13M |